APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Analysis and Forecast 2026-2032

23 December 2025200 pages

Choose your research edition.

Industry ResearchPorcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include China Animal Husbandry Co., Ltd., Yongshun Biological, Tiankang, Zoetis, Ruipu Biological, Qilu Animal Health, Pulike Biological, Jinyu and Sinopharm Animal Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales, projected growth trends, production technology, application and end-user industry.

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Company

China Animal Husbandry Co., Ltd.

Yongshun Biological

Tiankang

Zoetis

Ruipu Biological

Qilu Animal Health

Pulike Biological

Jinyu

Sinopharm Animal Health

Dahuanong

Boehringer Ingelheim

Phibro Animal Health

MSD Animal Health

Komipharm

Ceva

CAVAC

Bioveta

Agrovet

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type

Live vaccines

Inactivated vaccines

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application

Government bidding

Market sales

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live vaccines Major Manufacturers Table 3. Inactivated vaccines Major Manufacturers Table 4. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Government bidding Major Manufacturers Table 6. Market sales Major Manufacturers Table 7. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends Table 8. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers Table 9. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges Table 10. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints Table 11. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (k units) Table 18. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032) & (k units) Table 19. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price (USD/unit) of Manufacturers (2021-2026) Table 26. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers, Product Type & Application Table 29. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 39. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (k units) Table 40. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2026) & (USD/unit) Table 43. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2027-2032) & (USD/unit) Table 44. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 51. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (k units) Table 52. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2026) & (USD/unit) Table 55. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2027-2032) & (USD/unit) Table 56. China Animal Husbandry Co., Ltd. Company Information Table 57. China Animal Husbandry Co., Ltd. Business Overview Table 58. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 59. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 60. China Animal Husbandry Co., Ltd. Recent Development Table 61. Yongshun Biological Company Information Table 62. Yongshun Biological Business Overview Table 63. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 64. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 65. Yongshun Biological Recent Development Table 66. Tiankang Company Information Table 67. Tiankang Business Overview Table 68. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 70. Tiankang Recent Development Table 71. Zoetis Company Information Table 72. Zoetis Business Overview Table 73. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 75. Zoetis Recent Development Table 76. Ruipu Biological Company Information Table 77. Ruipu Biological Business Overview Table 78. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 80. Ruipu Biological Recent Development Table 81. Qilu Animal Health Company Information Table 82. Qilu Animal Health Business Overview Table 83. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 85. Qilu Animal Health Recent Development Table 86. Pulike Biological Company Information Table 87. Pulike Biological Business Overview Table 88. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 90. Pulike Biological Recent Development Table 91. Jinyu Company Information Table 92. Jinyu Business Overview Table 93. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 95. Jinyu Recent Development Table 96. Sinopharm Animal Health Company Information Table 97. Sinopharm Animal Health Business Overview Table 98. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 100. Sinopharm Animal Health Recent Development Table 101. Dahuanong Company Information Table 102. Dahuanong Business Overview Table 103. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 105. Dahuanong Recent Development Table 106. Boehringer Ingelheim Company Information Table 107. Boehringer Ingelheim Business Overview Table 108. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 110. Boehringer Ingelheim Recent Development Table 111. Phibro Animal Health Company Information Table 112. Phibro Animal Health Business Overview Table 113. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 115. Phibro Animal Health Recent Development Table 116. MSD Animal Health Company Information Table 117. MSD Animal Health Business Overview Table 118. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 120. MSD Animal Health Recent Development Table 121. Komipharm Company Information Table 122. Komipharm Business Overview Table 123. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 125. Komipharm Recent Development Table 126. Ceva Company Information Table 127. Ceva Business Overview Table 128. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 130. Ceva Recent Development Table 131. CAVAC Company Information Table 132. CAVAC Business Overview Table 133. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 135. CAVAC Recent Development Table 136. Bioveta Company Information Table 137. Bioveta Business Overview Table 138. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 140. Bioveta Recent Development Table 141. Agrovet Company Information Table 142. Agrovet Business Overview Table 143. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 145. Agrovet Recent Development Table 146. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 147. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 148. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 149. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (k units) Table 150. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2021-2026) & (USD/unit) Table 151. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2027-2032) & (USD/unit) Table 152. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 153. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 154. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 155. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (k units) Table 156. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2021-2026) & (USD/unit) Table 157. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2027-2032) & (USD/unit) Table 158. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 162. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 163. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 164. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2021-2026) & (USD/unit) Table 165. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2027-2032) & (USD/unit) Table 166. United States Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 167. Canada Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 168. Mexico Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 169. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 170. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 171. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 172. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (k units) Table 173. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2021-2026) & (USD/unit) Table 174. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2027-2032) & (USD/unit) Table 175. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 176. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 177. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 178. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (k units) Table 179. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2021-2026) & (USD/unit) Table 180. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2027-2032) & (USD/unit) Table 181. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 185. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 186. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 187. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2021-2026) & (USD/unit) Table 188. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2027-2032) & (USD/unit) Table 189. Germany Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 190. France Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 191. U.K. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 192. Italy Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Russia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 194. Spain Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 195. Netherlands Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 196. Switzerland Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Sweden Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Poland Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 199. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 200. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 201. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 202. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (k units) Table 203. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2021-2026) & (USD/unit) Table 204. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2027-2032) & (USD/unit) Table 205. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 206. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 207. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 208. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (k units) Table 209. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2021-2026) & (USD/unit) Table 210. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2027-2032) & (USD/unit) Table 211. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 212. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 213. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 214. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (k units) Table 215. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2021-2026) & (USD/unit) Table 216. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2027-2032) & (USD/unit) Table 217. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 218. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 219. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 220. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (k units) Table 221. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2021-2026) & (USD/unit) Table 222. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2027-2032) & (USD/unit) Table 223. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 224. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 225. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 226. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 227. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 228. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 229. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2021-2026) & (USD/unit) Table 230. Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2027-2032) & (USD/unit) Table 231. Japan Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 232. South Korea Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 233. India Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 234. Australia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 235. Taiwan Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 236. Southeast Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 237. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 238. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 239. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 240. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (k units) Table 241. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2021-2026) & (USD/unit) Table 242. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2027-2032) & (USD/unit) Table 243. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 244. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 245. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 246. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (k units) Table 247. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2021-2026) & (USD/unit) Table 248. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2027-2032) & (USD/unit) Table 249. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 250. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 251. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 252. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 253. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 254. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 255. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2021-2026) & (USD/unit) Table 256. SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2027-2032) & (USD/unit) Table 257. Brazil Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 258. Argentina Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 259. Chile Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 260. Colombia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 261. Peru Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 262. Saudi Arabia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 263. Israel Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 264. UAE Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 265. Turkey Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 266. Iran Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 267. Egypt Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 268. Key Raw Materials Table 269. Raw Materials Key Suppliers Table 270. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List Table 271. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List Table 272. Research Programs/Design for This Report Table 273. Authors List of This Report Table 274. Secondary Sources Table 275. Primary Sources List of Figures Figure 1. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Image Figure 2. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live vaccines Image Figure 5. Inactivated vaccines Image Figure 6. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Government bidding Image Figure 9. Market sales Image Figure 10. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2032) & (k units) Figure 16. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales YoY (2021-2032) & (k units) Figure 19. Europe Porcine Reproducti

Scope & coverage.

Types
  • Live vaccines
  • Inactivated vaccines
Applications
  • Government bidding
  • Market sales
Companies covered
  • China Animal Husbandry Co., Ltd.
  • Yongshun Biological
  • Tiankang
  • Zoetis
  • Ruipu Biological
  • Qilu Animal Health
  • Pulike Biological
  • Jinyu
  • Sinopharm Animal Health
  • Dahuanong
  • Boehringer Ingelheim
  • Phibro Animal Health
  • MSD Animal Health
  • Komipharm
  • Ceva
  • CAVAC
  • Bioveta
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Type
  3. 1.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live vaccines
  5. 1.2.3 Inactivated vaccines
  6. 1.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Application
  7. 1.3.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Government bidding
  9. 1.3.3 Market sales
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Dynamics
  1. 2.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
  2. 2.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers
  3. 2.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges
  4. 2.4 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region
  3. 3.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region
  9. 3.4.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturers
  6. 4.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Tier 1, Tier 2, and Tier 3
5 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Type
  1. 5.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type
  2. 5.1.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
  6. 5.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type
6 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Application
  1. 6.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application
  2. 6.1.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
  6. 6.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application
7 Company Profiles
  1. 7.1 China Animal Husbandry Co., Ltd.
  2. 7.1.1 China Animal Husbandry Co., Ltd. Company Information
  3. 7.1.2 China Animal Husbandry Co., Ltd. Business Overview
  4. 7.1.3 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  6. 7.1.5 China Animal Husbandry Co., Ltd. Recent Developments
  7. 7.2 Yongshun Biological
  8. 7.2.1 Yongshun Biological Company Information
  9. 7.2.2 Yongshun Biological Business Overview
  10. 7.2.3 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  12. 7.2.5 Yongshun Biological Recent Developments
  13. 7.3 Tiankang
  14. 7.3.1 Tiankang Company Information
  15. 7.3.2 Tiankang Business Overview
  16. 7.3.3 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  18. 7.3.5 Tiankang Recent Developments
  19. 7.4 Zoetis
  20. 7.4.1 Zoetis Company Information
  21. 7.4.2 Zoetis Business Overview
  22. 7.4.3 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  24. 7.4.5 Zoetis Recent Developments
  25. 7.5 Ruipu Biological
  26. 7.5.1 Ruipu Biological Company Information
  27. 7.5.2 Ruipu Biological Business Overview
  28. 7.5.3 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  30. 7.5.5 Ruipu Biological Recent Developments
  31. 7.6 Qilu Animal Health
  32. 7.6.1 Qilu Animal Health Company Information
  33. 7.6.2 Qilu Animal Health Business Overview
  34. 7.6.3 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  36. 7.6.5 Qilu Animal Health Recent Developments
  37. 7.7 Pulike Biological
  38. 7.7.1 Pulike Biological Company Information
  39. 7.7.2 Pulike Biological Business Overview
  40. 7.7.3 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  42. 7.7.5 Pulike Biological Recent Developments
  43. 7.8 Jinyu
  44. 7.8.1 Jinyu Company Information
  45. 7.8.2 Jinyu Business Overview
  46. 7.8.3 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  48. 7.8.5 Jinyu Recent Developments
  49. 7.9 Sinopharm Animal Health
  50. 7.9.1 Sinopharm Animal Health Company Information
  51. 7.9.2 Sinopharm Animal Health Business Overview
  52. 7.9.3 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  54. 7.9.5 Sinopharm Animal Health Recent Developments
  55. 7.10 Dahuanong
  56. 7.10.1 Dahuanong Company Information
  57. 7.10.2 Dahuanong Business Overview
  58. 7.10.3 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  60. 7.10.5 Dahuanong Recent Developments
  61. 7.11 Boehringer Ingelheim
  62. 7.11.1 Boehringer Ingelheim Company Information
  63. 7.11.2 Boehringer Ingelheim Business Overview
  64. 7.11.3 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  66. 7.11.5 Boehringer Ingelheim Recent Developments
  67. 7.12 Phibro Animal Health
  68. 7.12.1 Phibro Animal Health Company Information
  69. 7.12.2 Phibro Animal Health Business Overview
  70. 7.12.3 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  72. 7.12.5 Phibro Animal Health Recent Developments
  73. 7.13 MSD Animal Health
  74. 7.13.1 MSD Animal Health Company Information
  75. 7.13.2 MSD Animal Health Business Overview
  76. 7.13.3 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  78. 7.13.5 MSD Animal Health Recent Developments
  79. 7.14 Komipharm
  80. 7.14.1 Komipharm Company Information
  81. 7.14.2 Komipharm Business Overview
  82. 7.14.3 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  84. 7.14.5 Komipharm Recent Developments
  85. 7.15 Ceva
  86. 7.15.1 Ceva Company Information
  87. 7.15.2 Ceva Business Overview
  88. 7.15.3 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  90. 7.15.5 Ceva Recent Developments
  91. 7.16 CAVAC
  92. 7.16.1 CAVAC Company Information
  93. 7.16.2 CAVAC Business Overview
  94. 7.16.3 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  96. 7.16.5 CAVAC Recent Developments
  97. 7.17 Bioveta
  98. 7.17.1 Bioveta Company Information
  99. 7.17.2 Bioveta Business Overview
  100. 7.17.3 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  102. 7.17.5 Bioveta Recent Developments
  103. 7.18 Agrovet
  104. 7.18.1 Agrovet Company Information
  105. 7.18.2 Agrovet Business Overview
  106. 7.18.3 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  108. 7.18.5 Agrovet Recent Developments
8 North America
  1. 8.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  2. 8.1.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
  5. 8.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  6. 8.2.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
  9. 8.3 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  10. 8.3.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  2. 9.1.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  6. 9.2.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  10. 9.3.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  2. 10.1.1 China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
  5. 10.2 China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  6. 10.2.1 China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  2. 11.1.1 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  6. 11.2.1 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  10. 11.3.1 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  2. 12.1.1 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  6. 12.2.1 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  10. 12.3.1 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Analysis
  2. 13.1.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
  6. 13.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
  9. 13.2.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst